Current Issue


Editor-In-Chief, Chester “Trip” Buckenmaier III, MD, COL (ret.), MC, USA

Better late than never

Pam and I are presently hiding from the heat of summer 2022 in the lakes region of central Maine. Pam’s family has maintained a cabin in the area for over 100 years. We are indeed fortunate to have the means to travel to cooler climates within the United States. At the same time, so many Americans must withstand the daily onslaught of over 90° F temperatures.

read more

NAFLD to MAFLD? New Terminology Urged for Fatty Liver Disease

International experts recommend replacing the disease acronym nonalcoholic fatty liver disease (NAFLD) with metabolic (dysfunction)-associated fatty liver disease (MAFLD); the new terminology would allow additional reasons for liver disease and more clearly specifies the probable reason for illness, according to a recent veterans study.

read more

Hemorrhagic Mortality A Problem for APL Patients

Even though the rate of complete remission of acute promyelocytic leukemia (APL) is currently more than 90% because of the use of all-trans retinoic acid (ATRA) with arsenic trioxide (ATO), hemorrhagic mortality has emerged as the most significant barrier to APL-induced remission, according to a new study.

read more